Sandoz Bolsters US Ophthalmic Portfolio With Aflibercept Approval

Launch Date Of Eylea Biosimilar Uncertain As ‘Complicated’ Court Proceedings Continue

 
• By David Wallace
  
USA flag reflected in eye
Sandoz has received FDA approval for its Enzeevu rival to Eylea • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products